Clinical trial
SMS - Study of Somatic Mutations Using Genome Sequencing
NCT06851052 is registered in ClinicalTrials.gov with The Wellcome Sanger Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SMS - Study of Somatic Mutations Using Genome Sequencing
- Lead sponsor
- The Wellcome Sanger Institute
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- October 1, 2016
- Completion date
- July 14, 2028
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
somatic mutation